(Q53658820)

English

Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma: a Southwest Oncology Group study.

scientific article published in October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16138364

Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma: a Southwest Oncology Group study. (English)

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16138364

phase II clinical trial

0 references

transitional cell carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ulka N Vaishampayan

1

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16138364

James R Faulkner

2

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16138364

Eric J Small

3

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16138364

Bruce G Redman

4

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16138364

Wayne L Keiser

5

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16138364

Daniel P Petrylak

6

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16138364

E David Crawford

7

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16138364

language of work or name

0 references

publication date

1 October 2005

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16138364

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16138364

104

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16138364

1627-1632

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16138364

8

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16138364

Treating refractory advanced or metastatic urothelial carcinoma with interleukin-2: a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

21 January 2018

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

Carboplatin-based chemotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of adjuvant chemotherapy for locally advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

Topotecan in previously treated advanced urothelial carcinoma: an ECOG phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of bladder cancer trials in the European Organization for Research and Treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21370

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21370

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16138364

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16138364

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53658820&oldid=1568145328"